The Effects of Intensive Glycemic Control on Neuropathy in the VA Cooperative Study on Type II Diabetes Mellitus (VA CSDM)

This publication has 11 references indexed in Scilit:

• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial
  Diabetes Care, 1995
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
  Diabetes Research and Clinical Practice, 1995
• The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
  Annals of Internal Medicine, 1995
• The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus
  New England Journal of Medicine, 1993
• Glycemic Control and Complications in Type II Diabetes: Design of a feasibility trial
  Diabetes Care, 1992
• Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group
  Diabetes, 1988
• Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
  BMJ, 1986
• Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis
  Neurology, 1986
• Correlations Among Autonomic, Sensory, and Motor Neural Function Tests in Untreated Non-insulin-dependent Diabetic Individuals
  Diabetes Care, 1985